Initial commercialization of the EVO Viva lens, including the first patient implant, has begun, STAAR Surgical announced in a press release.
“Our presbyopia-correcting EVO Viva lens is aimed at patients in their 40s and 50s who struggle with near vision and the burdens associated with wearing reading glasses,” Caren Mason, president and CEO of STAAR Surgical, said in the release.
Consumer websites are available in French, Dutch and Spanish, with more local language websites forthcoming, the release said.
The EVO and EVO Viva versions of the ICL are not approved (Read more...)
Uncategorized